Watson gets FDA approval for generic Yasmin
MORRISTOWN, N.J. The Food and Drug Administration has approved a generic oral contraceptive made by Watson Pharmaceuticals, the drug maker said Tuesday.
Watson announced the FDA’s approval of Zarah (drospirenone and ethinyl estradiol tablets) in the 3 mg/0.03 mg strength. The drug is a generic version of Bayer’s Yasmin.
Watson said it has started shipping the drug, though Bayer’s patent litigation suit against the company concerning the drug remains pending in the U.S. District Court for the Southern District of New York.
Yasmin and generic versions had sales of around $97 million during the 12 months ended in June, according to IMS Health.
Wallace named GSK Consumer Healthcare VP
PITTSBURGH GlaxoSmithKline Consumer Healthcare on Tuesday named Stacy Wallace to the newly created role of VP customer marketing and 360° Insights.
Under Wallace’s direction, the customer marketing and 360° Insights team will continue the development and execution of category visions and strategies in the area of health and wellness and in the creation of insight-led innovative and fully evaluated shopper marketing programs, the company stated.
Wallace joined GSK in 2002 working in the United Kingdom on the nutritional healthcare business. She joined the GSK Consumer Healthcare U.S. business in 2008 as the sales strategy director and most recently served as director of category marketing and 360° Insights.
Wallace was recently profiled in the “Who’s Who in Shopper Marketing,” a publication that recognizes the best in the industry in insight-driven, customized retail shopper marketing activation.
ProPhase Labs picks agency of record
DOYLESTOWN, Pa. ProPhase Labs on Tuesday announced it has retained media solutions company Women’s Marketing as its agency of record. The agency will work closely with ProPhase Labs to develop and implement high-impact media campaigns for Cold-Eeze and Kids-Eeze across a variety of networks, the company stated.
The ad campaigns coincide with improvements to Cold-Eeze and Kids-Eeze product and packaging, including a Kids-Eeze line of symptom relievers in a "chew" form.
“ProPhase Labs has been working hard to further improve our current product lines and bring new, effective products to market,” stated Ted Karkus, ProPhase CEO. “We are excited to join with WMI to create a dynamic media campaign that will introduce our new and improved products to new consumers and reinvigorate our loyal customers.”